These discrepancies could be attributed to (i) the different clinical characteristics of the different study cohorts, including age and distribution of sex, (ii) children with obesity having no other major complications such as vascular lesions and glucose metabolism disorders, and (iii) the difference in measurement, which may provide different results for PK2 levels. This evidence concerns the gene PROK2 and glucose metabolism disease.